Only For
NDC 73006-119
Product Information
Only For is a OTC MONOGRAPH NOT FINAL-approved product labeled by O4 Global Trading Usa, Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a blue product. This product entry covers the primary NDC 73006-119 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
AD01
Code Structure Chart
Product Details
What is NDC 73006-119?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ACETAMINOPHEN (UNII: 362O9ITL9D)
- ACETAMINOPHEN (UNII: 362O9ITL9D) (Active Moiety)
- DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40)
- DIPHENHYDRAMINE (UNII: 8GTS82S83M) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- FD&C BLUE NO. 1--ALUMINUM LAKE (UNII: J9EQA3S2JM)
- HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)
- MAGNESIUM PALMITOSTEARATE (UNII: R4OXA9G5BV)
- STARCH, CORN (UNII: O8232NY3SJ)
- MICROCRYSTALLINE CELLULOSE 101 (UNII: 7T9FYH5QMK)
- POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
- POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1092189 - acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG Oral Tablet
- RxCUI: 1092189 - acetaminophen 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet
- RxCUI: 1092189 - APAP 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.